📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

LRR-protein RNH1 dampens the inflammasome activation and is associated with COVID-19 severity (2022)

First Author: Bombaci G

Attributed to: Understanding the pathogenesis of Epstein-Barr virus-associated complications arising in patients treated with immune checkpoint regulators funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.26508/lsa.202101226

PubMed Identifier: 35256513

Publication URI: http://europepmc.org/abstract/MED/35256513

Type: Journal Article/Review

Parent Publication: Life Science Alliance

Issue: 6

ISSN: 2575-1077